Implanet's SqualeTM anterior cervical cage received FDA 510(k) approval, the devicemaker said April 11.
The device has been usesd in more than 15,000 cases globally, according to a news release. It features a wide range of implants for interbody fusion.
Implanet's CEO, Ludovic Lastennet, said SqualeTM is expected to launch in the U.S. by summer.